A Multicenter, Randomized, Controlled Trial of Electroacupuncture for Perimenopause Women with Mild-Moderate Depression

Sheng Li, Zhao-Feng Li, Qian Wu, Xiao-Chuan Guo, Zhen-Hua Xu, Xiao-Bin Li, Rong Chen, Dao-You Zhou, Cong Wang, Quan Duan, Jian Sun, Ding Luo, Min-Ying Li, Jun-Ling Wang, Hui Xie, Li-Hua Xuan, Sheng-Yong Su, Dong-Mian Huang, Zhi-Shun Liu, Wen-Bin Fu, Sheng Li, Zhao-Feng Li, Qian Wu, Xiao-Chuan Guo, Zhen-Hua Xu, Xiao-Bin Li, Rong Chen, Dao-You Zhou, Cong Wang, Quan Duan, Jian Sun, Ding Luo, Min-Ying Li, Jun-Ling Wang, Hui Xie, Li-Hua Xuan, Sheng-Yong Su, Dong-Mian Huang, Zhi-Shun Liu, Wen-Bin Fu

Abstract

Objective: Up to 62% of perimenopausal women have depression symptoms. However, there is no efficacy treatment. The aim of this study is to compare the clinical efficacy and safety of EA therapy and escitalopram on perimenopause women with mild-moderate depressive symptom.

Method: A multicenter, randomized, positive-controlled clinical trial was conducted at 6 hospitals in China. 242 perimenopause women with mild-moderate depressive symptom were recruited and randomly assigned to receive 36 sessions of EA treatment or escitalopram treatment. The primary outcome measure was the 17-item Hamilton Depression Rating Scale (HAMD-17). The secondary outcome measures include menopause-specific quality of life (MENQOL) and serum sexual hormones which include estrogen, follicle-stimulating hormone, and luteinizing hormone.

Results: 221 (91.3%) completed the study, including 116 in the EA group and 105 in the escitalopram group. The baseline levels of demographic and outcome measurements were similar in the two groups. In the intervention period, there was no difference between two groups. However, in the follow-up, both HAMD-17 and MENQOL were significantly decreased, and at week 24 the mean differences were -2.23 and -8.97, respectively. There were no significant differences in the change of serum sexual hormones between the two groups. No serious adverse events occurred.

Conclusion: EA treatment is effective and safe in relieving depression symptom and improving the quality of life in the perimenopausal depression. Further research is needed to understand long-term efficacy and explore the mechanism of this intervention. This study is registered with ClinicalTrials.gov NCT02423694.

Figures

Figure 1
Figure 1
Study flow diagram. EA means electroacupuncture treatment; ES means escitalopram treatment.
Figure 2
Figure 2
HAMD-17 score and MENQOL score at baseline and weeks 4, 8, 12, 16, 20, and 24. Error bars represent standard error. EA means electroacupuncture treatment; ES means escitalopram treatment.

References

    1. Noble R. E. Depression in women. Metabolism. 2005;54(5, supplement 1):49–52. doi: 10.1016/j.metabol.2005.01.014.
    1. de Kruif M., Spijker A. T., Molendijk M. L. Depression during the perimenopause: A meta-analysis. Journal of Affective Disorders. 2016;206:174–180. doi: 10.1016/j.jad.2016.07.040.
    1. Brinton R. D., Yao J., Yin F., Mack W. J., Cadenas E. Perimenopause as a neurological transition state. Nature Reviews Endocrinology. 2015;11(7):393–405. doi: 10.1038/nrendo.2015.82.
    1. Studd J., Nappi R. E. Reproductive depression. Gynecological Endocrinology. 2012;28(1):42–45. doi: 10.3109/09513590.2012.651932.
    1. Studd J. Personal view: hormones and depression in women. Climacteric. 2015;18(1):3–5. doi: 10.3109/13697137.2014.918595.
    1. Ruan X., Cui Y., Du F., et al. Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women. Journal of Psychosomatic Obstetrics & Gynecology. 2016:1–9.
    1. Baber R. J., Panay N., Fenton A. 2016 IMS Recommendations on womens midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150. doi: 10.3109/13697137.2015.1129166.
    1. Toffol E., Heikinheimo O., Partonen T. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review. Menopause. 2015;22(5):564–578. doi: 10.1097/GME.0000000000000323.
    1. Floter-Radestad A. Hormone therapy in menopause can increase the risk of ovarian cancer. Läkartidningen. 2015;112
    1. Antoine C., Ameye L., Paesmans M., De Azambuja E., Rozenberg S. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries. Maturitas. 2016;84:81–88. doi: 10.1016/j.maturitas.2015.11.010.
    1. Alexander I. M. The History of Hormone Therapy Use and Recent Controversy Related to Heart Disease and Breast Cancer Arising from Prevention Trial Outcomes. Journal of Midwifery & Women’s Health. 2012;57(6):547–557. doi: 10.1111/j.1542-2011.2012.00247.x.
    1. Prentice R. L. Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Seminars in Reproductive Medicine. 2014;32(6):419–425. doi: 10.1055/s-0034-1384624.
    1. Beakley B. D., Kaye A. M., Kaye A. D. Tramadol, pharmacology, side effects, and serotonin syndrome: A review. Pain Physician. 2015;18(4):395–400.
    1. Venzke L., Calvert J. F., Jr., Gilbertson B. A randomized trial of acupuncture for vasomotor symptoms in post-menopausal women. Complementary Therapies in Medicine. 2010;18(2):59–66. doi: 10.1016/j.ctim.2010.02.002.
    1. Rosenberg K. Acupuncture Relieves Menopause-Related Vasomotor Symptoms. American Journal of Nursing. 2016;116(9):p. 68. doi: 10.1097/01.NAJ.0000494701.16735.d5.
    1. Dørmœnen A., Heimdal M. R., Wang C. E. A., Grimsgaard A. S. Depression in postmenopause: a study on a subsample of the Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study. Menopause. 2011;18(5):525–530. doi: 10.1097/gme.0b013e3181f9f89f.
    1. Hachul H., Garcia T. K. P., MacIel A. L., Yagihara F., Tufik S., Bittencourt L. Acupuncture improves sleep in postmenopause in a randomized, double-blind, placebo-controlled study. Climacteric. 2013;16(1):36–40. doi: 10.3109/13697137.2012.698432.
    1. Baccetti S., da Frè M., Becorpi A., et al. Acupuncture and traditional Chinese medicine for hot flushes in menopause: a randomized trial. The Journal of Alternative and Complementary Medicine. 2014;20(7):550–557. doi: 10.1089/acm.2012.0499.
    1. Chiu H.-Y., Pan C.-H., Shyu Y.-K., Han B.-C., Tsai P.-S. Effects of acupuncture on menopause-related symptoms and quality of life in women in natural menopause: a meta-analysis of randomized controlled trials. Menopause. 2015;22(2):234–244. doi: 10.1097/gme.0000000000000260.
    1. Avis N. E., Coeytaux R. R., Isom S., Prevette K., Morgan T. Acupuncture in Menopause (AIM) study: A pragmatic, randomized controlled trial. Menopause. 2016;23(6):626–637. doi: 10.1097/GME.0000000000000597.
    1. Painovich J. M., Shufelt C. L., Azziz R., et al. A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause. 2012;19(1):54–61. doi: 10.1097/gme.0b013e31821f9171.
    1. MacPherson H., Altman D. G., Hammerschlag R., et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the consort statement. Acupuncture in Medicine. 2010;28(2):83–93. doi: 10.1136/aim.2009.001370.
    1. Harlow S. D., Gass M., Hall J. E., et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–395. doi: 10.1097/gme.0b013e31824d8f40.
    1. Arlington V. Diagnostic and statistical manual of mental disorders fifth edition DSM-5 TM. American Psychiatric Association; 2013.
    1. Organization W. H. The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. Vol. 10. Geneva, Geneva: World Health Organization; 1992.
    1. Ee C., Xue C., Chondros P., et al. Acupuncture for menopausal hot flashes. Annals of Internal Medicine. 2016;164(3):146–154. doi: 10.7326/M15-1380.
    1. Freeman E. W. Associations of depression with the transition to menopause. Menopause. 2010;17(4):823–827. doi: 10.1097/gme.0b013e3181db9f8b.
    1. Zhou J., Qu F., Sang X., Wang X., Nan R. Acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized chinese women: a randomized controlled trial. Evidence-Based Complementary and Alternative Medicine. 2011713274
    1. Jo J., Lee Y. J., Lee H. Effectiveness of acupuncture for primary ovarian insufficiency: A systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2015;2015 doi: 10.1155/2015/842180.842180
    1. Jo J., Lee Y. J., Lee H. Acupuncture for polycystic ovarian syndrome. Medicine. 2017;96(23):p. e7066. doi: 10.1097/MD.0000000000007066.
    1. Meng F., Duan P.-B., Zhu J., et al. Effect of Gua sha therapy on perimenopausal syndrome: a randomized controlled trial. Menopause. 2017;24(3):299–307.
    1. Wu Y., Jiang Y., He X., et al. 5-HT in the dorsal raphe nucleus is involved in the effects of 100-Hz electro-acupuncture on the pain-depression dyad in rats. Experimental and Therapeutic Medicine. 2017;14(1):107–114. doi: 10.3892/etm.2017.4479.
    1. Luo D., Ma R., Wu Y., et al. Mechanism underlying acupuncture-ameliorated depressive behaviors by enhancing glial glutamate transporter in chronic unpredictable mild stress (CUMS) rats. Medical Science Monitor. 2017;23:3080–3087. doi: 10.12659/MSM.902549.
    1. Jiang H., Zhang X., Wang Y., et al. Mechanisms underlying the antidepressant response of acupuncture via PKA/CREB signaling pathway. Neural Plasticity. 2017;2017:11. doi: 10.1155/2017/4135164.4135164
    1. Tegeler C. H., Tegeler C. L., Cook J. F., Lee S. W., Pajewski N. M. Reduction in menopause-related symptoms associated with use of a noninvasive neurotechnology for autocalibration of neural oscillations. Menopause. 2015;22(6):650–655. doi: 10.1097/GME.0000000000000422.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa